Login to Your Account

Otic uptick for Tokai; reverse merger to support ENT pipeline

By Marie Powers
News Editor

Thursday, December 22, 2016

Shares of Tokai Pharmaceuticals Inc. (NASDAQ:TKAI) enjoyed a 50 percent boost Thursday morning after shareholders agreed to a share purchase agreement with privately held Otic Pharma Ltd.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription